Results 171 to 180 of about 98,172 (269)

Mebendazole effectively overcomes imatinib resistance by dual-targeting BCR/ABL oncoprotein and β-tubulin in chronic myeloid leukemia cells. [PDF]

Korean J Physiol Pharmacol
Yang L, Du Z, Peng Y, Zhang W, Feng W, Yuan Y.   +5 more
europepmc   +1 more source

Ontogeny of natural killer cells and T cells by analysis of BCR–ABL rearrangement from patients with chronic myelogenous leukaemia [PDF]

, 2000
Eun Kyung Cho, Dae Seog Heo, Jae Goo Seol, Eul‐Ju Seo, Hyun Sook, Eun Shil Kim, Young Yiul Lee, Byoung Kook Kim, Noe Kyeong Kim   +8 more
openalex   +1 more source

Rational Approach to New Chemical Entities with Antiproliferative Activity on Ab1 Tyrosine Kinase Encoded by the BCR-ABL Gene: An Hierarchical Biochemoinformatics Analysis. [PDF]

Pharmaceuticals (Basel)
Sanches VHDS, Lobato CC, Silva LB, Dos Santos IVF, Barros ES, Maciel AA, Ferreira EFB, da Costa KS, Espejo-Román JM, Rosa JMC, Kimani NM, Santos CBR.   +11 more
europepmc   +1 more source

Are aberrant BCR–ABL transcripts more common than previously thought? [PDF]

, 2000
G. A. Wilson, Elisabeth Vandenberghe, Rebecca C. Pollitt, Douglas C. Rees, Anne Goodeve, I. R. Peake, John T. Reilly   +6 more
openalex   +1 more source

BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia

Oncogene, 2014
C. Xu, H. Fu, Liang Gao, Lu Wang, Wen Wang, Jingxin Li, Yan Li, L. Dou, Xiaoning Gao, Xin Luo, Y. Jing, Chim Cs, X. Zheng, Li Yu   +13 more
semanticscholar   +1 more source

PBA2, a novel inhibitor of the β-catenin/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation. [PDF]

Mol Cancer
Yang K, Fu K, Zhang H, Wang X, To KKW, Yang C, Wang F, Chen ZS, Fu L.   +8 more
europepmc   +1 more source

The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells

, 1996
Peter T. Rowley, Peter C. Keng, Barbara A. Kosciolek   +2 more
openalex   +1 more source

In Silico Molecular Modeling of Four New Afatinib Derived Molecules Targeting the Inhibition of the Mutated Form of BCR-ABL T315I. [PDF]

Molecules
Rocha KML, Nascimento ÉCM, de Jesus RCC, Martins JBL.   +3 more
europepmc   +1 more source

Signal transmission of BCR-ABL in chronic myelogenous leukemia.

, 1995
Kohei Miyazawa, K Toyama
openalex   +2 more sources

The Effect of Bcr-Abl Protein Tyrosine Kinase on Maturation and Proliferation of Primitive Haematopoietic Cells [PDF]

, 2000
Anne‐Marie Buckle, Rachel Mottram, Andrew Pierce, Guy Lucas, Nigel H. Russell, Jaleel A. Miyan, Anthony D. Whetton   +6 more
openalex   +1 more source